CSIMarket Company Name, Ticker, Customers, else..
 
In8bio Inc   (NASDAQ: INAB)
 

In8bio Inc's Suppliers Performance

INAB's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
INAB Costs vs Sales of Suppliers Growth

• More on INAB Suppliers






In8bio Inc's Comment on Supply Chain


The company sources raw materials, manufacturing devices, active pharmaceutical ingredients, lentiviral vectors, and finished products for preclinical research and clinical trials. It holds multi-year agreements with multiple GMP cell therapy laboratory facilities to manufacture product candidates for Phase 1 and Phase 2/3 clinical trials. These agreements provide medical technologists with direct access to the facilities to assist and operate alongside GMP facility staff and enable manufacturing on a per-patient basis. The company plans to enter into agreements with third-party manufacturers and facilities for future production and is evaluating the feasibility and costs of establishing manufacturing capabilities for future development and commercial quantities. All manufacturing activities must comply with FDA and other regulatory agency requirements.

In8bio Inc's Comment on Supply Chain


The company sources raw materials, manufacturing devices, active pharmaceutical ingredients, lentiviral vectors, and finished products for preclinical research and clinical trials. It holds multi-year agreements with multiple GMP cell therapy laboratory facilities to manufacture product candidates for Phase 1 and Phase 2/3 clinical trials. These agreements provide medical technologists with direct access to the facilities to assist and operate alongside GMP facility staff and enable manufacturing on a per-patient basis. The company plans to enter into agreements with third-party manufacturers and facilities for future production and is evaluating the feasibility and costs of establishing manufacturing capabilities for future development and commercial quantities. All manufacturing activities must comply with FDA and other regulatory agency requirements.







INAB's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
In8bio Inc 21.41 0.00 -18.67 17
SUBTOTAL 0.00 0.00 0.00 -


Sources: In8bio Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on In8bio Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.